Prognostic signatures have become popular tools in cancer research, but it turns out signatures made of random genes are prognostic as well.
Prognostic signatures have become popular tools in cancer research, but it turns out signatures made of random genes are prognostic as well.
After a roller-coaster of an October, The Scientist resumes publication under new ownership.
A prescription for educating the public on the value of using animals in medical research
Advances in cell-culture technologies are paving the way to the complete elimination of animals from the laboratory.
How next-generation sequencing technologies will drive a new era of research on non-model organisms.
A legal remedy is needed to curb unethical “guest authorship” in medical journals.
US border policy and fences threaten wildlife across the continent.
After a historic UN meeting, global efforts must be coordinated against noncommunicable diseases to thwart the world’s leading causes of death and disability.
Investing more federal dollars in life science research may save the US economy.
By extending its reach beyond science, the field of omics will change the way we live our lives.